An updated meta-analysis of hemodynamics markers of prognosis in patients with pulmonary hypertension due to left heart disease

被引:6
|
作者
Baratto, Claudia [1 ]
Caravita, Sergio [1 ,2 ]
Soranna, Davide [3 ]
Dewachter, Celine [4 ]
Bondue, Antoine [4 ]
Zambon, Antonella [3 ,5 ]
Badano, Luigi P. [1 ,6 ]
Parati, Gianfranco [1 ,6 ]
Vachiery, Jean-Luc [4 ]
机构
[1] Osped San Luca, Dept Cardiovasc Neural & Metab Sci, Ist Auxol Italiano IRCCS, Milan, Italy
[2] Univ Bergamo, Dept Management Informat & Prod Engn, Dalmine, BG, Italy
[3] IRCCS Ist Auxol Italiano, Biostat Unit, Milan, Italy
[4] Clin Univ Bruxelles, Hop Acad Erasme, Dept Cardiol, Brussels, Belgium
[5] Univ Milano Bicocca, Dept Stat & Quantitat Methods, Milan, Italy
[6] Univ Milano Bicocca, Dept Med & Surg, Milan, Italy
关键词
hemodynamics; pulmonary hypertension; left heart disease; prognosis; RIGHT-VENTRICULAR FUNCTION; ARTERIAL CAPACITANCE; PRESSURE-GRADIENT; FAILURE; LEVOSIMENDAN; PREDICTOR; OUTCOMES; BIAS;
D O I
10.1002/pul2.12145
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pulmonary hypertension (PH) is associated with a poor prognosis in left heart disease (LHD). We sought to provide an updated analysis on the association of hemodynamic variables, such as pulmonary vascular resistance (PVR), pulmonary artery compliance (PAC), and diastolic pressure gradient (DPG), with prognosis in PH-LHD, through a systematic literature review. Sixteen articles were identified, including 9600 patients with LHD, heterogeneous in terms of age, sex, and etiology of cardiac disease. In this large population, PVR (hazard ratio [HR], 1.07; 95% confidence interval [CI]: 1.05-1.0), DPG (HR, 1.02; 95% CI: 1.01-1.02) and PAC (HR, 0.76; 95% CI: 0.69-0.84) were associated with an increased risk of adverse outcome, albeit with a less solid performance of DPG. Similar results were found when hemodynamic variables were analyzed according to the thresholds commonly applied in clinical practice, or subdividing cohorts according to the underlying LHD. Furthermore, cumulative metanalysis indicated that these results are consistently stable since 2018. Thus, PVR, DPG and PAC have an established prognostic value in PH-LHD. These results are consistent through the years and unlikely to change with further studies.
引用
收藏
页数:18
相关论文
共 50 条
  • [21] Pulmonary hypertension in left heart disease
    Opitz, C. F.
    Glaeser, S.
    Ewert, R.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2009, 134 : S167 - S169
  • [22] Prevalence and significance of pulmonary hypertension among hospitalized patients with left heart disease
    Farmakis, Ioannis T.
    Hobohm, Lukas
    Valerio, Luca
    Keller, Karsten
    Schmidt, Kai-Helge
    von Bardeleben, Ralph Stephan
    Lurz, Philipp
    Rosenkranz, Stephan
    Konstantinides, Stavros V.
    Giannakoulas, George
    RESPIRATORY MEDICINE, 2024, 234
  • [23] Pulmonary venous hypertension or pulmonary hypertension due to left heart disease
    Adatia, Ian
    Kulik, Tom
    Mullen, Mary
    PROGRESS IN PEDIATRIC CARDIOLOGY, 2009, 27 (1-2) : 35 - 42
  • [24] Pathophysiology and Diagnosis of Pulmonary Hypertension Due to Left Heart Disease
    Charalampopoulos, Athanasios
    Lewis, Robert
    Hickey, Peter
    Durrington, Charlotte
    Elliot, Charlie
    Condliffe, Robin
    Sabroe, Ian
    Kiely, David G.
    FRONTIERS IN MEDICINE, 2018, 5
  • [25] How to define pulmonary hypertension due to left heart disease
    Gerges, Mario
    Gerges, Christian
    Lang, Irene M.
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48 (02) : 553 - 555
  • [26] Corrected MRI Pulmonary Transit Time for Identification of Combined Precapillary and Postcapillary Pulmonary Hypertension in Patients With Left Heart Disease
    Gong, Chao
    Guo, Xinli
    Wan, Ke
    Chen, Chen
    Chen, Xiaoling
    Guo, Jiajun
    He, Juan
    Yin, Lidan
    Wen, Bi
    Pu, Shoufang
    Chen, Yucheng
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2023, 57 (05) : 1518 - 1528
  • [27] Metabolic Syndrome and Pulmonary Hypertension Due to Left Heart Disease
    Vanderpool, Rebecca R.
    Shterental, Sebastian
    Bachman, Timothy N.
    Gladwin, Mark T.
    Simon, Marc A.
    CIRCULATION, 2014, 130
  • [28] Comparative effectiveness of sildenafil for pulmonary hypertension due to left heart disease with HFrEF
    Jiang, Rong
    Wang, Lan
    Zhu, Chang-Tai
    Yuan, Ping
    Pudasaini, Bigyan
    Zhao, Qin-Hua
    Gong, Su-Gang
    He, Jing
    Liu, Jin-Ming
    Hu, Qing-Hua
    HYPERTENSION RESEARCH, 2015, 38 (12) : 829 - 839
  • [29] Current Understanding of Circulating Biomarkers in Pulmonary Hypertension Due to Left Heart Disease
    Todd, Noah
    Lai, Yen-Chun
    FRONTIERS IN MEDICINE, 2020, 7
  • [30] Determinants and prognostic implications of the negative diastolic pulmonary pressure gradient in patients with pulmonary hypertension due to left heart disease
    Nagy, Aniko Ilona
    Venkateshvaran, Ashwin
    Merkely, Bela
    Lund, Lars H.
    Manouras, Aristomenis
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 (01) : 88 - 97